Mehmet Demir

Genomize

Genomize is a fast-growing and dynamic bioinformatics company founded in 2014 which specializes in the analysis of genomic data. Adopting quality and customer-orientation as main principles, Genomize delivers its diverse academic assets to its customers accurately, rapidly and reliably. Genomize's SEQ platform focuses on the analysis of Next Generation Sequencing (NGS) data. SEQ provides a full-fletch solution from raw data to clinical report generation, automates data transfer and back-up, offers tools for data and organization management, provides detailed bioinformatics analysis, and enables users to access these from any device connected to the internet. SEQ platform is being actively used by hospitals, genetic diagnosis centers, and research institutes, whose focus is analysis of NGS data. The company processed almost 80,000 samples from 50 centers and more than 160 users in three different countries count SEQ as their core bioinformatics solution.